Published in Vaccine Weekly, September 10th, 2003
"We have completed 75% of trials on animals. We will be starting human trials in December," said Anil Chawla, head of research and development at Panacea Biotech, a New Delhi-based biotechnology firm.
Ever since the U.S. Food and Drug Administration approved Anthrax Vaccine Adsorbed - the vaccine currently used in the United States and other countries - 30 years ago, scientists have been trying to improve on it.
The old preparation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.